Ambrosetti DC - Search Results

1

New insights into the molecular basis of progressive myoclonus epilepsy: a multiprotein complex with cystatin B.

Di Giaimo R, Riccio M, Santi S, Galeotti C, Ambrosetti DC, Melli M. Di Giaimo R, et al. Among authors: ambrosetti dc. Hum Mol Genet. 2002 Nov 1;11(23):2941-50. doi: 10.1093/hmg/11.23.2941. Hum Mol Genet. 2002. PMID: 12393805

2

Cell-specific expression of the epm1 (cystatin B) gene in developing rat cerebellum.

Riccio M, Santi S, Dembic M, Di Giaimo R, Cipollini E, Costantino-Ceccarini E, Ambrosetti D, Maraldi NM, Melli M. Riccio M, et al. Neurobiol Dis. 2005 Oct;20(1):104-14. doi: 10.1016/j.nbd.2005.02.012. Neurobiol Dis. 2005. PMID: 16137571

3

Tollip is a mediator of protein sumoylation.

Ciarrocchi A, D'Angelo R, Cordiglieri C, Rispoli A, Santi S, Riccio M, Carone S, Mancia AL, Paci S, Cipollini E, Ambrosetti D, Melli M. Ciarrocchi A, et al. PLoS One. 2009;4(2):e4404. doi: 10.1371/journal.pone.0004404. Epub 2009 Feb 9. PLoS One. 2009. PMID: 19198660 Free PMC article.

4

Synthetic alleles at position 121 define a functional domain of human interleukin-1 beta.

Ambrosetti DC, Palla E, Mirtella A, Galeotti C, Solito E, Navarra P, Parente L, Melli M. Ambrosetti DC, et al. Eur J Biochem. 1996 Jun 1;238(2):308-16. doi: 10.1111/j.1432-1033.1996.0308z.x. Eur J Biochem. 1996. PMID: 8681939 Free article.

5

An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma.

Reggiani F, Sauta E, Torricelli F, Zanetti E, Tagliavini E, Santandrea G, Gobbi G, Damia G, Bellazzi R, Ambrosetti D, Ciarrocchi A, Sancisi V. Reggiani F, et al. Mol Cancer. 2021 Apr 6;20(1):63. doi: 10.1186/s12943-021-01357-z. Mol Cancer. 2021. PMID: 33823854 Free PMC article. No abstract available.

6

Histone Deacetylase Inhibitors Repress Tumoral Expression of the Proinvasive Factor RUNX2.

Sancisi V, Gandolfi G, Ambrosetti DC, Ciarrocchi A. Sancisi V, et al. Among authors: ambrosetti dc. Cancer Res. 2015 May 1;75(9):1868-82. doi: 10.1158/0008-5472.CAN-14-2087. Epub 2015 Mar 13. Cancer Res. 2015. PMID: 25769725

7

Multiple roles and context-specific mechanisms underlying YAP and TAZ-mediated resistance to anti-cancer therapy.

Reggiani F, Gobbi G, Ciarrocchi A, Ambrosetti DC, Sancisi V. Reggiani F, et al. Among authors: ambrosetti dc. Biochim Biophys Acta Rev Cancer. 2020 Jan;1873(1):188341. doi: 10.1016/j.bbcan.2020.188341. Epub 2020 Jan 10. Biochim Biophys Acta Rev Cancer. 2020. PMID: 31931113 Review.

8

The Hippo pathway modulates resistance to BET proteins inhibitors in lung cancer cells.

Gobbi G, Donati B, Do Valle IF, Reggiani F, Torricelli F, Remondini D, Castellani G, Ambrosetti DC, Ciarrocchi A, Sancisi V. Gobbi G, et al. Among authors: ambrosetti dc. Oncogene. 2019 Oct;38(42):6801-6817. doi: 10.1038/s41388-019-0924-1. Epub 2019 Aug 12. Oncogene. 2019. PMID: 31406246

9

CSNK1A1, KDM2A, and LTB4R2 Are New Druggable Vulnerabilities in Lung Cancer.

Sauta E, Reggiani F, Torricelli F, Zanetti E, Tagliavini E, Santandrea G, Gobbi G, Strocchi S, Paci M, Damia G, Bellazzi R, Ambrosetti D, Ciarrocchi A, Sancisi V. Sauta E, et al. Cancers (Basel). 2021 Jul 12;13(14):3477. doi: 10.3390/cancers13143477. Cancers (Basel). 2021. PMID: 34298691 Free PMC article.

10

Mechanisms underlying differential responses to FGF signaling.

Dailey L, Ambrosetti D, Mansukhani A, Basilico C. Dailey L, et al. Cytokine Growth Factor Rev. 2005 Apr;16(2):233-47. doi: 10.1016/j.cytogfr.2005.01.007. Epub 2005 Mar 5. Cytokine Growth Factor Rev. 2005. PMID: 15863038 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page